TLDR Senate prepares to vote on a bill to temporarily restore government operations after 38-day shutdown. The CLARITY Act and Responsible Financial Innovation Act face delays due to the shutdown. Senator Lummis’ crypto bill was supposed to advance through Senate committees by fall but faces setbacks. The shutdown has taken priority, delaying crypto regulation discussions [...] The post U.S. Senate Votes on Government Reopening Amid Crypto Regulation Delays appeared first on Blockonomi.TLDR Senate prepares to vote on a bill to temporarily restore government operations after 38-day shutdown. The CLARITY Act and Responsible Financial Innovation Act face delays due to the shutdown. Senator Lummis’ crypto bill was supposed to advance through Senate committees by fall but faces setbacks. The shutdown has taken priority, delaying crypto regulation discussions [...] The post U.S. Senate Votes on Government Reopening Amid Crypto Regulation Delays appeared first on Blockonomi.

U.S. Senate Votes on Government Reopening Amid Crypto Regulation Delays

2025/11/08 01:23
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Senate prepares to vote on a bill to temporarily restore government operations after 38-day shutdown.
  • The CLARITY Act and Responsible Financial Innovation Act face delays due to the shutdown.
  • Senator Lummis’ crypto bill was supposed to advance through Senate committees by fall but faces setbacks.
  • The shutdown has taken priority, delaying crypto regulation discussions and other legislative efforts.
  • Republican plans to advance the crypto bill by fall now seem unlikely due to the ongoing political gridlock.

As the U.S. government shutdown stretches into its 38th day, the Senate is preparing to vote on a funding bill to temporarily reopen federal operations. However, this has left a crucial issue unresolved due to the stalled progress of comprehensive cryptocurrency regulation.

Crypto Regulation Bill Stuck

The Digital Asset Market Structure bill, known as the CLARITY Act in the House and the Responsible Financial Innovation Act in the Senate, aims to provide a detailed framework for crypto regulation in the United States. This legislation was expected to move forward during the fall.

However, the ongoing government shutdown has put a halt to progress, as lawmakers are primarily focused on restoring government operations. Senator Cynthia Lummis, a strong advocate for the bill, had planned for the legislation to be advanced through both the Senate Banking and Agriculture Committees.

These milestones were supposed to be achieved by the fall. However, as the shutdown continues, the timeline for this legislation looks increasingly uncertain, with the holidays approaching and political tensions high.

Government Shutdown Takes Priority

With the shutdown affecting numerous federal agencies and many employees working without pay, discussions surrounding crypto regulation have taken a backseat. While Republican and Democratic lawmakers have continued talks on the digital asset market structure bill, there is little indication that meaningful progress will occur in the near future.

The shutdown’s impact has delayed not only crypto regulation but also other legislative efforts. The Senate’s focus remains on passing a continuing resolution to restore government functions, leaving the future of crypto legislation hanging in the balance. Initially, Republican lawmakers had aimed to move the crypto bill through the Senate Banking Committee by September,       by the Agriculture Committee in October.

They hoped to have the legislation signed into law by 2026. However, the ongoing shutdown and political gridlock make it increasingly unlikely that these goals will be met. As the Senate prepares to vote on a bill to end the shutdown, it remains unclear when the crypto regulatory framework will gain the momentum it needs to move forward.

The post U.S. Senate Votes on Government Reopening Amid Crypto Regulation Delays appeared first on Blockonomi.

Market Opportunity
Union Logo
Union Price(U)
$0.001053
$0.001053$0.001053
+3.33%
USD
Union (U) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09